anti-VEGF antibody (Beijing Tri-Prime Gene Pharmaceutical)

N/A

Report date: 2025/03/14 16:29:13

Base Information

Drug Nameanti-VEGF antibody (Beijing Tri-Prime Gene Pharmaceutical)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionVascular endothelial growth factor receptor antagonists

TargetsVascular endothelial growth factor receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBeijing Tri-Prime Gene Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeijing Tri-Prime Gene Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A